HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Naoki Yoshimura Yoshio Ootaki Yoshiya Toyoda Masahiro Yamaguchi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hasegawa, T. Articles by Yamaguchi, M. Search for Related Content PubMed PubMed Citation Articles by Hasegawa, T. Articles by Yamaguchi, M. Related Collections Myocardial infarction

J Thorac Cardiovasc Surg 2004;127:1697-1702
© 2004 The American Association for Thoracic Surgery

Surgery for congenital heart disease

Evaluation of heart fatty acid–binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery

^a Department of Cardiothoracic Surgery, Kobe Children's Hospital, Kobe, Japan

Received for publication October 2, 2003; revisions received January 18, 2004; accepted for publication February 9, 2004.

^* Address for reprints: Tomomi Hasegawa, MD, Department of Cardiothoracic Surgery, Kobe Children's Hospital, 1-1-1 Takakura-dai, Suma-ku, Kobe 654-0081, Japan

OBJECTIVES: Perioperative myocardial damage is a major determinant of postoperative cardiac dysfunction for congenital heart disease. Heart fatty acid–binding protein is reported to be a rapid marker of perioperative myocardial damage that peaks earlier than creatine kinase isoenzyme MB or cardiac troponin T in adults. The objective of this study was to assess the suitability of using serum concentrations of heart fatty acid–binding protein for evaluation of perioperative myocardial damage in pediatric cardiac surgery.

METHODS: After institutional review board approval and informed consent, 100 children undergoing open procedures for congenital heart disease were prospectively enrolled in the study. Mean age at operation was 4.9 ± 0.4 years. Serum concentrations of heart fatty acid–binding protein, creatine kinase isoenzyme MB, and cardiac troponin T were measured serially before operation and at 0, 1, 2, 3, and 6 hours after aortic declamping. Relationships between serum peak level of heart fatty acid–binding protein and intraoperative and postoperative clinical variables were evaluated.

RESULTS: Serum heart fatty acid–binding protein reached its peak level at 1 hour after declamping in 95 patients (95%), which was significantly earlier (P < .01) than serum creatine kinase isoenzyme MB or cardiac troponin T. In addition, serum heart fatty acid–binding protein level immediately after declamping correlated strongly with serum peak heart fatty acid–binding protein level (r = 0.91, P < .01). The serum peak level of heart fatty acid–binding protein correlated with those of creatine kinase isoenzyme MB (r = 0.77, P < .01) and cardiac troponin T (r = 0.80, P < .01). In the forward stepwise multiple regression analysis, age (P < .0001), aortic crossclamp time (P < .0001), the presence of a ventriculotomy (P < .001), and the lowest hematocrit level during cardiopulmonary bypass (P < .05) were significant intraoperative variables that influenced the release of heart fatty acid–binding protein. There were significant relationships between serum peak heart fatty acid–binding protein level and postoperative inotropic support, duration of intubation, and intensive care unit stay (P < .01 for each).

CONCLUSIONS: Heart fatty acid–binding protein is a rapid marker for assessment of myocardial damage and clinical outcome in pediatric cardiac surgery. In particular, serum heart fatty acid–binding protein level immediately after aortic declamping may be a potentially useful prognostic indicator of myocardial damage as well as clinical outcome in pediatric cardiac surgery.

This article has been cited by other articles:

				U. K. Chowdhury, V. Malik, R. Yadav, S. Seth, L. Ramakrishnan, M. Kalaivani, S. M. Reddy, G. K. Subramaniam, R. Govindappa, and M. Kakani Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1110 - 1119.e10. [Abstract] [Full Text] [PDF]

				L. H. Mildh, V. Pettila, H. I. Sairanen, and P. H. Rautiainen Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery Ann. Thorac. Surg., November 1, 2006; 82(5): 1643 - 1648. [Abstract] [Full Text] [PDF]

				M. Thielmann, P. Massoudy, A. Schmermund, M. Neuhauser, G. Marggraf, M. Kamler, U. Herold, I. Aleksic, K. Mann, M. Haude, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery Eur. Heart J., November 2, 2005; 26(22): 2440 - 2447. [Abstract] [Full Text] [PDF]

				T. Hasegawa, M. Yamaguchi, N. Yoshimura, and Y. Okita The dependence of myocardial damage on age and ischemic time in pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 192 - 198. [Abstract] [Full Text] [PDF]